Endothelial SIRT6 blunts stroke size and neurological deficit by preserving blood–brain barrier integrity: a translational study

Autor: Fabrizio Montecucco, Thomas F. Lüscher, Luca Liberale, Daniel S. Gaul, Giacomo Giacalone, Daria Vdovenko, Sarah Costantino, Julien Weber, Jürgen Pahla, Urs Eriksson, Maria Sessa, Giovanni G. Camici, Vanasa Nageswaran, Vera Fehr, Gerd A. Kullak-Ublick, Alexander Akhmedov, Aurora Semerano, Frank Ruschitzka, Christian M. Matter, Jürg H. Beer, Nicole R. Bonetti, Francesco Paneni
Přispěvatelé: University of Zurich, Camici, Giovanni G
Rok vydání: 2019
Předmět:
Cell death
medicine.medical_specialty
Endothelium
Ischemia
610 Medicine & health
030204 cardiovascular system & hematology
Blood–brain barrier
Neuroprotection
2705 Cardiology and Cardiovascular Medicine
Brain Ischemia
11459 Center for Molecular Cardiology
Brain ischemia
Mice
03 medical and health sciences
0302 clinical medicine
Internal medicine
Sirtuin 6
SIRT6
Animals
Humans
Sirtuins
Medicine
Middle cerebral artery occlusion
Stroke
030304 developmental biology
0303 health sciences
business.industry
Endothelial Cells
Infarction
Middle Cerebral Artery

Human brain
Ischaemia/reperfusion
Hypoxia (medical)
medicine.disease
Mice
Inbred C57BL

medicine.anatomical_structure
Endocrinology
Blood-Brain Barrier
10199 Clinic for Clinical Pharmacology and Toxicology
10209 Clinic for Cardiology
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Zdroj: European Heart Journal. 41:1575-1587
ISSN: 1522-9645
0195-668X
DOI: 10.1093/eurheartj/ehz712
Popis: Aims Aging is an established risk factor for stroke; genes regulating longevity are implicated in the pathogenesis of ischaemic stroke where to date, therapeutic options remain limited. The blood–brain barrier (BBB) is crucially involved in ischaemia/reperfusion (I/R) brain injury thus representing an attractive target for developing novel therapeutic agents. Given the role of endothelial cells in the BBB, we hypothesized that the endothelial-specific expression of the recently described longevity gene SIRT6 may exhibit protective properties in stroke. Methods and results SIRT6 endothelial expression was reduced following stroke. Endothelial-specific Sirt6 knockout (eSirt6−/−) mice, as well as animals in which Sirt6 overexpression was post-ischaemically induced, underwent transient middle cerebral artery occlusion (tMCAO). eSirt6−/− animals displayed increased infarct volumes, mortality, and neurological deficit after tMCAO, as compared to control littermates. Conversely, post-ischaemic Sirt6 overexpression decreased infarct size and neurological deficit. Analysis of ischaemic brain sections revealed increased BBB damage and endothelial expression of cleaved caspase-3 in eSIRT6−/− mice as compared to controls. In primary human brain microvascular endothelial cells (HBMVECs), hypoxia/reoxygenation (H/R) reduced SIRT6 expression and SIRT6 silencing impaired the barrier function (transendothelial resistance) similar to what was observed in mice exposed to I/R. Further, SIRT6-silenced HBMVECs exposed to H/R showed reduced viability, increased cleaved caspase-3 expression and reduced activation of the survival pathway Akt. In ischaemic stroke patients, SIRT6 expression was higher in those with short-term neurological improvement as assessed by NIHSS scale and correlated with stroke outcome. Conclusion Endothelial SIRT6 exerts a protective role in ischaemic stroke by blunting I/R-mediated BBB damage and thus, it may represent an interesting novel therapeutic target to be explored in future clinical investigation.
Databáze: OpenAIRE